![Cross-reactivity testing of Phospho-Insulin Receptor (Tyr1361) (84B2) Rabbit mAb with activated IGF-I receptors. Various amounts of activated recombinant IGF-I receptor cytoplasmic domain proteins were applied for Western blot analysis, using Phospho-Insulin Receptor (Tyr1361) (84B2) Rabbit mAb (upper) and Phospho-IGF-I Receptor (Tyr1315/1316) (19H7) Rabbit mAb #3024 (lower) respectively. The result showed that Phospho-Insulin Receptor (Tyr1361) (84B2) Rabbit mAb barely cross-reacts with activated IGF-I receptors.](http://www.bioprodhub.com/system/product_images/ab_products/1/sub_1/24152_3023_wb2_jp_070124.jpg)
Cross-reactivity testing of Phospho-Insulin Receptor (Tyr1361) (84B2) Rabbit mAb with activated IGF-I receptors. Various amounts of activated recombinant IGF-I receptor cytoplasmic domain proteins were applied for Western blot analysis, using Phospho-Insulin Receptor (Tyr1361) (84B2) Rabbit mAb (upper) and Phospho-IGF-I Receptor (Tyr1315/1316) (19H7) Rabbit mAb #3024 (lower) respectively. The result showed that Phospho-Insulin Receptor (Tyr1361) (84B2) Rabbit mAb barely cross-reacts with activated IGF-I receptors.
![Western blot analysis of CHO cells overexpressing human insulin receptors untreated or treated with insulin (100 nM for 5 min), using Phospho-Insulin Receptor β (Tyr1361) (84B2) Rabbit mAb (upper) and Insulin Receptor β (4B8) Rabbit mAb #3025(lower).](http://www.bioprodhub.com/system/product_images/ab_products/1/sub_1/24153_3023_wb_jp_070124.jpg)
Western blot analysis of CHO cells overexpressing human insulin receptors untreated or treated with insulin (100 nM for 5 min), using Phospho-Insulin Receptor β (Tyr1361) (84B2) Rabbit mAb (upper) and Insulin Receptor β (4B8) Rabbit mAb #3025(lower).